CAPLIN POINT LABORATORIES
Back to Balance Sheet
|
CAPLIN POINT LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹306 Cr | ₹331 Cr | ₹268 Cr | ₹208 Cr | ₹143 Cr |
What is the latest Total Current Liabilities ratio of CAPLIN POINT LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹306 Cr |
| Mar2024 | ₹331 Cr |
| Mar2023 | ₹268 Cr |
| Mar2022 | ₹208 Cr |
| Mar2021 | ₹143 Cr |
How is Total Current Liabilities of CAPLIN POINT LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹306 Cr | -7.51 | |
| Mar2024 | ₹331 Cr | 23.45 | |
| Mar2023 | ₹268 Cr | 29.04 | |
| Mar2022 | ₹208 Cr | 45.38 | |
| Mar2021 | ₹143 Cr | - | |
Compare Total Current Liabilities of peers of CAPLIN POINT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CAPLIN POINT LABORATORIES | ₹12,986.1 Cr | 8.8% | 2.4% | -19.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | 8.8% |
2.4% |
-19.2% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses